BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,899 | -17.2% | 2,647 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $120,598 | -9.7% | 2,647 | -19.6% | 0.00% | -25.0% |
| Q1 2023 | $133,524 | -25.9% | 3,292 | -6.9% | 0.00% | -33.3% |
| Q4 2022 | $180,281 | -5.6% | 3,537 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $191,000 | -17.7% | 3,537 | -1.9% | 0.01% | -12.5% |
| Q2 2022 | $232,000 | -51.5% | 3,605 | -41.6% | 0.01% | -42.9% |
| Q1 2022 | $478,000 | +100.0% | 6,173 | +120.9% | 0.01% | +100.0% |
| Q4 2021 | $239,000 | +4.4% | 2,794 | -1.7% | 0.01% | -12.5% |
| Q3 2021 | $229,000 | -1.3% | 2,841 | -1.2% | 0.01% | 0.0% |
| Q2 2021 | $232,000 | -1.7% | 2,876 | +3.2% | 0.01% | -11.1% |
| Q1 2021 | $236,000 | +3.5% | 2,787 | -2.0% | 0.01% | 0.0% |
| Q4 2020 | $228,000 | -0.4% | 2,844 | 0.0% | 0.01% | -10.0% |
| Q3 2020 | $229,000 | -10.9% | 2,844 | -4.9% | 0.01% | -23.1% |
| Q2 2020 | $257,000 | +4.9% | 2,991 | -0.7% | 0.01% | -13.3% |
| Q1 2020 | $245,000 | -2.4% | 3,012 | 0.0% | 0.02% | +15.4% |
| Q4 2019 | $251,000 | -63.0% | 3,012 | -61.2% | 0.01% | -65.8% |
| Q3 2019 | $679,000 | +6.9% | 7,769 | +0.9% | 0.04% | +5.6% |
| Q2 2019 | $635,000 | +198.1% | 7,701 | +193.5% | 0.04% | +176.9% |
| Q1 2019 | $213,000 | +1.4% | 2,624 | -17.7% | 0.01% | -7.1% |
| Q4 2018 | $210,000 | -55.8% | 3,189 | -48.2% | 0.01% | -50.0% |
| Q3 2018 | $475,000 | -20.2% | 6,161 | -23.4% | 0.03% | -26.3% |
| Q2 2018 | $595,000 | +9.6% | 8,048 | -3.6% | 0.04% | +11.8% |
| Q1 2018 | $543,000 | +56.9% | 8,346 | +55.9% | 0.03% | +61.9% |
| Q4 2017 | $346,000 | +7.1% | 5,353 | +3.9% | 0.02% | 0.0% |
| Q3 2017 | $323,000 | +8.0% | 5,150 | +4.3% | 0.02% | +5.0% |
| Q2 2017 | $299,000 | +75.9% | 4,936 | +51.1% | 0.02% | +81.8% |
| Q1 2017 | $170,000 | -11.0% | 3,266 | -24.2% | 0.01% | -15.4% |
| Q4 2016 | $191,000 | +3.2% | 4,308 | +11.2% | 0.01% | 0.0% |
| Q3 2016 | $185,000 | -15.5% | 3,873 | -20.0% | 0.01% | -18.8% |
| Q2 2016 | $219,000 | +5.3% | 4,841 | -4.3% | 0.02% | 0.0% |
| Q1 2016 | $208,000 | +66.4% | 5,057 | +54.5% | 0.02% | +60.0% |
| Q4 2015 | $125,000 | +14.7% | 3,274 | -1.3% | 0.01% | +11.1% |
| Q3 2015 | $109,000 | -60.5% | 3,317 | -16.2% | 0.01% | -59.1% |
| Q2 2015 | $276,000 | +3.4% | 3,959 | +1.7% | 0.02% | +4.8% |
| Q1 2015 | $267,000 | -86.7% | 3,894 | -85.8% | 0.02% | -87.2% |
| Q4 2014 | $2,011,000 | -15.6% | 27,442 | -17.4% | 0.16% | -13.2% |
| Q3 2014 | $2,384,000 | -1.2% | 33,222 | -0.4% | 0.19% | -0.5% |
| Q2 2014 | $2,412,000 | -12.5% | 33,367 | -11.0% | 0.19% | -16.7% |
| Q1 2014 | $2,757,000 | +2.1% | 37,482 | -3.5% | 0.23% | +0.9% |
| Q4 2013 | $2,701,000 | +9.8% | 38,845 | +3.7% | 0.23% | +1.3% |
| Q3 2013 | $2,461,000 | +587.4% | 37,470 | +625.5% | 0.22% | +555.9% |
| Q2 2013 | $358,000 | – | 5,165 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |